Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(immunotherapy). Showing records 1 – 30 of 1161 total matches.

[1] [2] [3] [4] [5] … [39]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters

1. Sunay, Melek ME. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.

Degree: 2015, Johns Hopkins University

 The tumor microenvironment is established and maintained through the complex interactions of tumor cells with host stromal elements. Therefore, therapies that target multiple cellular components… (more)

Subjects/Keywords: immunotherapy. cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sunay, M. M. (2015). Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/38006

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sunay, Melek ME. “Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.” 2015. Thesis, Johns Hopkins University. Accessed March 05, 2021. http://jhir.library.jhu.edu/handle/1774.2/38006.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sunay, Melek ME. “Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.” 2015. Web. 05 Mar 2021.

Vancouver:

Sunay MM. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. [Internet] [Thesis]. Johns Hopkins University; 2015. [cited 2021 Mar 05]. Available from: http://jhir.library.jhu.edu/handle/1774.2/38006.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sunay MM. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. [Thesis]. Johns Hopkins University; 2015. Available from: http://jhir.library.jhu.edu/handle/1774.2/38006

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

2. Shae, Daniel. Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.

Degree: PhD, Chemical Engineering, 2019, Vanderbilt University

 I detail the rational design and optimization of STING-NPs: a nanoparticle delivery platform that stimulates innate immunity and T cell activation through targeted activation of… (more)

Subjects/Keywords: Cancer Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shae, D. (2019). Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/10674

Chicago Manual of Style (16th Edition):

Shae, Daniel. “Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.” 2019. Doctoral Dissertation, Vanderbilt University. Accessed March 05, 2021. http://hdl.handle.net/1803/10674.

MLA Handbook (7th Edition):

Shae, Daniel. “Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.” 2019. Web. 05 Mar 2021.

Vancouver:

Shae D. Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. [Internet] [Doctoral dissertation]. Vanderbilt University; 2019. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/1803/10674.

Council of Science Editors:

Shae D. Design and Optimization of ‘Smart’ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. [Doctoral Dissertation]. Vanderbilt University; 2019. Available from: http://hdl.handle.net/1803/10674

3. Khare, Priyanka. Attenuation of gonadotropin secreting tumors by immunotherapy.

Degree: 2009, Jamia Hamdard University

newline Advisors/Committee Members: Javed, Saleem.

Subjects/Keywords: Immunotherapy

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khare, P. (2009). Attenuation of gonadotropin secreting tumors by immunotherapy. (Thesis). Jamia Hamdard University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/37387

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Khare, Priyanka. “Attenuation of gonadotropin secreting tumors by immunotherapy.” 2009. Thesis, Jamia Hamdard University. Accessed March 05, 2021. http://shodhganga.inflibnet.ac.in/handle/10603/37387.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Khare, Priyanka. “Attenuation of gonadotropin secreting tumors by immunotherapy.” 2009. Web. 05 Mar 2021.

Vancouver:

Khare P. Attenuation of gonadotropin secreting tumors by immunotherapy. [Internet] [Thesis]. Jamia Hamdard University; 2009. [cited 2021 Mar 05]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/37387.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Khare P. Attenuation of gonadotropin secreting tumors by immunotherapy. [Thesis]. Jamia Hamdard University; 2009. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/37387

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

4. Murphy, Katherine Anne. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.

Degree: PhD, Molecular, Cellular, Developmental Biology and Genetics, 2012, University of Minnesota

 Glioblastoma multiforme, the most aggressive form of glioma, is a lethal brain tumor with a dismal median survival of 15-19 months. Immunotherapy is a promising… (more)

Subjects/Keywords: Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Murphy, K. A. (2012). Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. (Doctoral Dissertation). University of Minnesota. Retrieved from http://purl.umn.edu/151476

Chicago Manual of Style (16th Edition):

Murphy, Katherine Anne. “Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.” 2012. Doctoral Dissertation, University of Minnesota. Accessed March 05, 2021. http://purl.umn.edu/151476.

MLA Handbook (7th Edition):

Murphy, Katherine Anne. “Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.” 2012. Web. 05 Mar 2021.

Vancouver:

Murphy KA. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. [Internet] [Doctoral dissertation]. University of Minnesota; 2012. [cited 2021 Mar 05]. Available from: http://purl.umn.edu/151476.

Council of Science Editors:

Murphy KA. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. [Doctoral Dissertation]. University of Minnesota; 2012. Available from: http://purl.umn.edu/151476


University of Melbourne

5. Segal Wasserman, Gabriela. Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma.

Degree: 2014, University of Melbourne

 The immune system protects the body from potential dangers and mediates the destruction of infected or tumoural cells. The elimination of these target cells is… (more)

Subjects/Keywords: cancer; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Segal Wasserman, G. (2014). Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/42223

Chicago Manual of Style (16th Edition):

Segal Wasserman, Gabriela. “Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma.” 2014. Doctoral Dissertation, University of Melbourne. Accessed March 05, 2021. http://hdl.handle.net/11343/42223.

MLA Handbook (7th Edition):

Segal Wasserman, Gabriela. “Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma.” 2014. Web. 05 Mar 2021.

Vancouver:

Segal Wasserman G. Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma. [Internet] [Doctoral dissertation]. University of Melbourne; 2014. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/11343/42223.

Council of Science Editors:

Segal Wasserman G. Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma. [Doctoral Dissertation]. University of Melbourne; 2014. Available from: http://hdl.handle.net/11343/42223


University of Oxford

6. Trenevska, Iva. Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy.

Degree: PhD, 2019, University of Oxford

 T-cell receptor mimic (TCRm) antibodies target a dual antigen epitope consisting of a peptide derived from an intracellular protein, and the major histocompatibility complex class… (more)

Subjects/Keywords: Cancer – Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Trenevska, I. (2019). Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:7b2b8f73-4af0-40ef-bf2c-0e09cc194da6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.780790

Chicago Manual of Style (16th Edition):

Trenevska, Iva. “Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy.” 2019. Doctoral Dissertation, University of Oxford. Accessed March 05, 2021. http://ora.ox.ac.uk/objects/uuid:7b2b8f73-4af0-40ef-bf2c-0e09cc194da6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.780790.

MLA Handbook (7th Edition):

Trenevska, Iva. “Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy.” 2019. Web. 05 Mar 2021.

Vancouver:

Trenevska I. Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy. [Internet] [Doctoral dissertation]. University of Oxford; 2019. [cited 2021 Mar 05]. Available from: http://ora.ox.ac.uk/objects/uuid:7b2b8f73-4af0-40ef-bf2c-0e09cc194da6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.780790.

Council of Science Editors:

Trenevska I. Developing anti-p53/HLA-A*0201 T-cell receptor mimic antibodies for cancer immunotherapy. [Doctoral Dissertation]. University of Oxford; 2019. Available from: http://ora.ox.ac.uk/objects/uuid:7b2b8f73-4af0-40ef-bf2c-0e09cc194da6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.780790

7. Alderson, Kory L. Deleterious Changes To The T Cell Compartment Following Immunotherapy.

Degree: 2009, University of Nevada – Reno

 Abstract: The combination of anti-CD40 and interleukin-2 is a potent immunotherapy regimen that results in synergistic anti-tumor responses. This has been demonstrated in multiple murine… (more)

Subjects/Keywords: Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alderson, K. L. (2009). Deleterious Changes To The T Cell Compartment Following Immunotherapy. (Thesis). University of Nevada – Reno. Retrieved from http://hdl.handle.net/11714/4059

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alderson, Kory L. “Deleterious Changes To The T Cell Compartment Following Immunotherapy.” 2009. Thesis, University of Nevada – Reno. Accessed March 05, 2021. http://hdl.handle.net/11714/4059.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alderson, Kory L. “Deleterious Changes To The T Cell Compartment Following Immunotherapy.” 2009. Web. 05 Mar 2021.

Vancouver:

Alderson KL. Deleterious Changes To The T Cell Compartment Following Immunotherapy. [Internet] [Thesis]. University of Nevada – Reno; 2009. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/11714/4059.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alderson KL. Deleterious Changes To The T Cell Compartment Following Immunotherapy. [Thesis]. University of Nevada – Reno; 2009. Available from: http://hdl.handle.net/11714/4059

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rutgers University

8. Newman, Jenna, 1993-. Utilization of influenza vaccination as an intratumoral immunotherapy for cancer.

Degree: PhD, Microbiology and Molecular Genetics, 2019, Rutgers University

In recent years, immunotherapy for cancer has yielded unprecedented response rates and increased survival in patients. Despite progress, a significant fraction of patients exhibit progression… (more)

Subjects/Keywords: Cancer  – Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Newman, Jenna, 1. (2019). Utilization of influenza vaccination as an intratumoral immunotherapy for cancer. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/61828/

Chicago Manual of Style (16th Edition):

Newman, Jenna, 1993-. “Utilization of influenza vaccination as an intratumoral immunotherapy for cancer.” 2019. Doctoral Dissertation, Rutgers University. Accessed March 05, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/61828/.

MLA Handbook (7th Edition):

Newman, Jenna, 1993-. “Utilization of influenza vaccination as an intratumoral immunotherapy for cancer.” 2019. Web. 05 Mar 2021.

Vancouver:

Newman, Jenna 1. Utilization of influenza vaccination as an intratumoral immunotherapy for cancer. [Internet] [Doctoral dissertation]. Rutgers University; 2019. [cited 2021 Mar 05]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/61828/.

Council of Science Editors:

Newman, Jenna 1. Utilization of influenza vaccination as an intratumoral immunotherapy for cancer. [Doctoral Dissertation]. Rutgers University; 2019. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/61828/

9. Jirakrit Saetang. Anti-cancer Immunologic Function of Recombinant Interleukin-18 .

Degree: คณะแพทยศาสตร์ ภาควิชาชีวเวชศาสตร์, 2018, Prince of Songkla University

Subjects/Keywords: Immunotherapy; Cancer Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saetang, J. (2018). Anti-cancer Immunologic Function of Recombinant Interleukin-18 . (Thesis). Prince of Songkla University. Retrieved from http://kb.psu.ac.th/psukb/handle/2016/12534

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Saetang, Jirakrit. “Anti-cancer Immunologic Function of Recombinant Interleukin-18 .” 2018. Thesis, Prince of Songkla University. Accessed March 05, 2021. http://kb.psu.ac.th/psukb/handle/2016/12534.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Saetang, Jirakrit. “Anti-cancer Immunologic Function of Recombinant Interleukin-18 .” 2018. Web. 05 Mar 2021.

Vancouver:

Saetang J. Anti-cancer Immunologic Function of Recombinant Interleukin-18 . [Internet] [Thesis]. Prince of Songkla University; 2018. [cited 2021 Mar 05]. Available from: http://kb.psu.ac.th/psukb/handle/2016/12534.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Saetang J. Anti-cancer Immunologic Function of Recombinant Interleukin-18 . [Thesis]. Prince of Songkla University; 2018. Available from: http://kb.psu.ac.th/psukb/handle/2016/12534

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Little, Nicole S. Investigating the co-evolution of tumor antigens and the anti-tumor immune response.

Degree: Department of Biochemistry and Microbiology, 2017, University of Victoria

 Background: High-grade serous carcinoma (HGSC) can exhibit high intratumoral heterogeneity (ITH). Despite a strong association between tumor-infiltrating lymphocytes (TIL) and survival in HGSC, ITH may… (more)

Subjects/Keywords: Cancer; Cancer Immunotherapy; Ovarian Cancer; Immunology; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Little, N. S. (2017). Investigating the co-evolution of tumor antigens and the anti-tumor immune response. (Masters Thesis). University of Victoria. Retrieved from https://dspace.library.uvic.ca//handle/1828/8503

Chicago Manual of Style (16th Edition):

Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Masters Thesis, University of Victoria. Accessed March 05, 2021. https://dspace.library.uvic.ca//handle/1828/8503.

MLA Handbook (7th Edition):

Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Web. 05 Mar 2021.

Vancouver:

Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Internet] [Masters thesis]. University of Victoria; 2017. [cited 2021 Mar 05]. Available from: https://dspace.library.uvic.ca//handle/1828/8503.

Council of Science Editors:

Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Masters Thesis]. University of Victoria; 2017. Available from: https://dspace.library.uvic.ca//handle/1828/8503


Victoria University of Wellington

11. Hunn, Martin Kent. Improving immunotherapy for high grade glioma.

Degree: 2015, Victoria University of Wellington

 Glioblastoma multiforme (GBM) is a malignant primary brain tumour that is almost always fatal. Conventional treatment modalities are limited by toxicity. T cell-based immunotherapy is… (more)

Subjects/Keywords: Glioma; Immunotherapy; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hunn, M. K. (2015). Improving immunotherapy for high grade glioma. (Doctoral Dissertation). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/4869

Chicago Manual of Style (16th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Doctoral Dissertation, Victoria University of Wellington. Accessed March 05, 2021. http://hdl.handle.net/10063/4869.

MLA Handbook (7th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Web. 05 Mar 2021.

Vancouver:

Hunn MK. Improving immunotherapy for high grade glioma. [Internet] [Doctoral dissertation]. Victoria University of Wellington; 2015. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10063/4869.

Council of Science Editors:

Hunn MK. Improving immunotherapy for high grade glioma. [Doctoral Dissertation]. Victoria University of Wellington; 2015. Available from: http://hdl.handle.net/10063/4869


University of Otago

12. Bouwer, Anthea Lynne. Role of NK cells in DC-based immunotherapy of melanoma .

Degree: 2011, University of Otago

 Natural killer (NK) cells were first identified by their ability to kill tumour or virally infected cells without prior sensitization. In spite of this, the… (more)

Subjects/Keywords: NK cells; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bouwer, A. L. (2011). Role of NK cells in DC-based immunotherapy of melanoma . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/1619

Chicago Manual of Style (16th Edition):

Bouwer, Anthea Lynne. “Role of NK cells in DC-based immunotherapy of melanoma .” 2011. Doctoral Dissertation, University of Otago. Accessed March 05, 2021. http://hdl.handle.net/10523/1619.

MLA Handbook (7th Edition):

Bouwer, Anthea Lynne. “Role of NK cells in DC-based immunotherapy of melanoma .” 2011. Web. 05 Mar 2021.

Vancouver:

Bouwer AL. Role of NK cells in DC-based immunotherapy of melanoma . [Internet] [Doctoral dissertation]. University of Otago; 2011. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10523/1619.

Council of Science Editors:

Bouwer AL. Role of NK cells in DC-based immunotherapy of melanoma . [Doctoral Dissertation]. University of Otago; 2011. Available from: http://hdl.handle.net/10523/1619


McMaster University

13. Rathmann, Stephanie. Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry.

Degree: PhD, 2020, McMaster University

 This thesis describes a general platform for the synthesis of radiolabelled antibody recruiting small molecules (R-ARMs) for combination radio and immune recruitment therapies. The novel… (more)

Subjects/Keywords: Cancer; Immunotherapy; Radiotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rathmann, S. (2020). Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/25928

Chicago Manual of Style (16th Edition):

Rathmann, Stephanie. “Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry.” 2020. Doctoral Dissertation, McMaster University. Accessed March 05, 2021. http://hdl.handle.net/11375/25928.

MLA Handbook (7th Edition):

Rathmann, Stephanie. “Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry.” 2020. Web. 05 Mar 2021.

Vancouver:

Rathmann S. Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry. [Internet] [Doctoral dissertation]. McMaster University; 2020. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/11375/25928.

Council of Science Editors:

Rathmann S. Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies using Bio-orthogonal Chemistry. [Doctoral Dissertation]. McMaster University; 2020. Available from: http://hdl.handle.net/11375/25928


Victoria University of Wellington

14. Bilbrough, Timothy. Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds.

Degree: 2017, Victoria University of Wellington

 Peptide vaccines can generate antigen-specific immune responses against tumours. However, peptides on their own are not usually immunogenic and require an adjuvant to ensure antigen-presenting… (more)

Subjects/Keywords: Immunotherapy; Adjuvant; Glycolipid

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bilbrough, T. (2017). Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds. (Masters Thesis). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/9097

Chicago Manual of Style (16th Edition):

Bilbrough, Timothy. “Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds.” 2017. Masters Thesis, Victoria University of Wellington. Accessed March 05, 2021. http://hdl.handle.net/10063/9097.

MLA Handbook (7th Edition):

Bilbrough, Timothy. “Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds.” 2017. Web. 05 Mar 2021.

Vancouver:

Bilbrough T. Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds. [Internet] [Masters thesis]. Victoria University of Wellington; 2017. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10063/9097.

Council of Science Editors:

Bilbrough T. Designing distribution of adjuvants: Synthesis of lipidated nucleic acid adjuvant compounds. [Masters Thesis]. Victoria University of Wellington; 2017. Available from: http://hdl.handle.net/10063/9097


University of Otago

15. Win, Stephanie Joy. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .

Degree: 2011, University of Otago

 Virus-like particles (VLP) have been shown to be useful nanoscale platforms in a diverse range of applications including their use as vaccines. They can act… (more)

Subjects/Keywords: Virus-Like Particles; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Win, S. J. (2011). Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/1733

Chicago Manual of Style (16th Edition):

Win, Stephanie Joy. “Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .” 2011. Doctoral Dissertation, University of Otago. Accessed March 05, 2021. http://hdl.handle.net/10523/1733.

MLA Handbook (7th Edition):

Win, Stephanie Joy. “Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .” 2011. Web. 05 Mar 2021.

Vancouver:

Win SJ. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . [Internet] [Doctoral dissertation]. University of Otago; 2011. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10523/1733.

Council of Science Editors:

Win SJ. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . [Doctoral Dissertation]. University of Otago; 2011. Available from: http://hdl.handle.net/10523/1733

16. Hu, Hong-Ming. Priming of therapeutic T cells for adoptive immunotherapy.

Degree: PhD, 2003, Oregon Health Sciences University

Subjects/Keywords: Immunotherapy; Adoptive

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hu, H. (2003). Priming of therapeutic T cells for adoptive immunotherapy. (Doctoral Dissertation). Oregon Health Sciences University. Retrieved from doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146

Chicago Manual of Style (16th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Doctoral Dissertation, Oregon Health Sciences University. Accessed March 05, 2021. doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

MLA Handbook (7th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Web. 05 Mar 2021.

Vancouver:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Internet] [Doctoral dissertation]. Oregon Health Sciences University; 2003. [cited 2021 Mar 05]. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

Council of Science Editors:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Doctoral Dissertation]. Oregon Health Sciences University; 2003. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146


Cornell University

17. Chandrasekaran, Siddarth. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis.

Degree: PhD, Biomedical Engineering, 2015, Cornell University

 Metastasis of primary tumor accounts for 90% of all deaths in cancer patients. Interaction between cells in the primary tumor is known to play an… (more)

Subjects/Keywords: Cancer Metastasis; Drug Delivery; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chandrasekaran, S. (2015). Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis. (Doctoral Dissertation). Cornell University. Retrieved from http://hdl.handle.net/1813/41158

Chicago Manual of Style (16th Edition):

Chandrasekaran, Siddarth. “Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis.” 2015. Doctoral Dissertation, Cornell University. Accessed March 05, 2021. http://hdl.handle.net/1813/41158.

MLA Handbook (7th Edition):

Chandrasekaran, Siddarth. “Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis.” 2015. Web. 05 Mar 2021.

Vancouver:

Chandrasekaran S. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis. [Internet] [Doctoral dissertation]. Cornell University; 2015. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/1813/41158.

Council of Science Editors:

Chandrasekaran S. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis. [Doctoral Dissertation]. Cornell University; 2015. Available from: http://hdl.handle.net/1813/41158


Vanderbilt University

18. Dockery, Mary Diana. Focused Ultrasound for the Generation of Cancer Immunotherapy.

Degree: MS, Biomedical Engineering, 2016, Vanderbilt University

 Cancer immunotherapies, which seek to arm the patient’s own immune system for personalized therapy, are a promising option for effective elimination of tumors. Focused ultrasound… (more)

Subjects/Keywords: immunotherapy; focused ultrasound; breast cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dockery, M. D. (2016). Focused Ultrasound for the Generation of Cancer Immunotherapy. (Thesis). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/14703

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dockery, Mary Diana. “Focused Ultrasound for the Generation of Cancer Immunotherapy.” 2016. Thesis, Vanderbilt University. Accessed March 05, 2021. http://hdl.handle.net/1803/14703.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dockery, Mary Diana. “Focused Ultrasound for the Generation of Cancer Immunotherapy.” 2016. Web. 05 Mar 2021.

Vancouver:

Dockery MD. Focused Ultrasound for the Generation of Cancer Immunotherapy. [Internet] [Thesis]. Vanderbilt University; 2016. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/1803/14703.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dockery MD. Focused Ultrasound for the Generation of Cancer Immunotherapy. [Thesis]. Vanderbilt University; 2016. Available from: http://hdl.handle.net/1803/14703

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

19. Bright, Vanessa Rochelle. Multimodal nanoparticles for cancer therapy and imaging.

Degree: MS, Chemical and Physical Biology, 2012, Vanderbilt University

 In this thesis, the power of synthetic chemistry and colloidal nanotechnology are employed in the advancement of cell therapy and imaging. A new approach to… (more)

Subjects/Keywords: nebulization; nanoparticles; Immunotherapy; NIR dye

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bright, V. R. (2012). Multimodal nanoparticles for cancer therapy and imaging. (Thesis). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/14622

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bright, Vanessa Rochelle. “Multimodal nanoparticles for cancer therapy and imaging.” 2012. Thesis, Vanderbilt University. Accessed March 05, 2021. http://hdl.handle.net/1803/14622.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bright, Vanessa Rochelle. “Multimodal nanoparticles for cancer therapy and imaging.” 2012. Web. 05 Mar 2021.

Vancouver:

Bright VR. Multimodal nanoparticles for cancer therapy and imaging. [Internet] [Thesis]. Vanderbilt University; 2012. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/1803/14622.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bright VR. Multimodal nanoparticles for cancer therapy and imaging. [Thesis]. Vanderbilt University; 2012. Available from: http://hdl.handle.net/1803/14622

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University College London (University of London)

20. Baban, Babak. The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer.

Degree: PhD, 1998, University College London (University of London)

 In the view of side effects and many other problems of conventional methods in treating cancer such as chemotherapy or radiotherapy, now a days, immunotherapy(more)

Subjects/Keywords: 610; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baban, B. (1998). The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer. (Doctoral Dissertation). University College London (University of London). Retrieved from https://discovery.ucl.ac.uk/id/eprint/10102229/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284829

Chicago Manual of Style (16th Edition):

Baban, Babak. “The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer.” 1998. Doctoral Dissertation, University College London (University of London). Accessed March 05, 2021. https://discovery.ucl.ac.uk/id/eprint/10102229/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284829.

MLA Handbook (7th Edition):

Baban, Babak. “The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer.” 1998. Web. 05 Mar 2021.

Vancouver:

Baban B. The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer. [Internet] [Doctoral dissertation]. University College London (University of London); 1998. [cited 2021 Mar 05]. Available from: https://discovery.ucl.ac.uk/id/eprint/10102229/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284829.

Council of Science Editors:

Baban B. The evaluation of a heat-killed suspension of Mycobacterium vaccae as an immunomodulating agent in the treatment of cancer. [Doctoral Dissertation]. University College London (University of London); 1998. Available from: https://discovery.ucl.ac.uk/id/eprint/10102229/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284829


McMaster University

21. Afsahi, Arya. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.

Degree: MSc, 2015, McMaster University

Introduction: Manipulation of the immune system to eliminate cancer, known as cancer immunotherapy, is an emerging field that has shown impressive clinical success and promise.… (more)

Subjects/Keywords: Immunology; T cell; Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Afsahi, A. (2015). Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/18413

Chicago Manual of Style (16th Edition):

Afsahi, Arya. “Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.” 2015. Masters Thesis, McMaster University. Accessed March 05, 2021. http://hdl.handle.net/11375/18413.

MLA Handbook (7th Edition):

Afsahi, Arya. “Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.” 2015. Web. 05 Mar 2021.

Vancouver:

Afsahi A. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. [Internet] [Masters thesis]. McMaster University; 2015. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/11375/18413.

Council of Science Editors:

Afsahi A. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. [Masters Thesis]. McMaster University; 2015. Available from: http://hdl.handle.net/11375/18413


Boston University

22. Kim, Susie. Recent advancements in cancer immunotherapeutics.

Degree: MS, Medical Sciences, 2015, Boston University

 Cancer affects a wide range of organs and tissues within the body and epidemiologically is forecasted to affect almost half of the world's population. As… (more)

Subjects/Keywords: Medicine; Cancer; Immunotherapy; Review

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, S. (2015). Recent advancements in cancer immunotherapeutics. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/16217

Chicago Manual of Style (16th Edition):

Kim, Susie. “Recent advancements in cancer immunotherapeutics.” 2015. Masters Thesis, Boston University. Accessed March 05, 2021. http://hdl.handle.net/2144/16217.

MLA Handbook (7th Edition):

Kim, Susie. “Recent advancements in cancer immunotherapeutics.” 2015. Web. 05 Mar 2021.

Vancouver:

Kim S. Recent advancements in cancer immunotherapeutics. [Internet] [Masters thesis]. Boston University; 2015. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/2144/16217.

Council of Science Editors:

Kim S. Recent advancements in cancer immunotherapeutics. [Masters Thesis]. Boston University; 2015. Available from: http://hdl.handle.net/2144/16217


University of California – San Francisco

23. Williams, Jasper Zee. Engineering T cells with diverse mechanisms for improved tumor recognition precision.

Degree: Pharmaceutical Sciences and Pharmacogenomics, 2019, University of California – San Francisco

 Engineered T cells are proven cancer therapeutics capable of executing potent antigen-dependent cell killing, and have gained FDA-approval after unprecedented results against certain blood cancers.… (more)

Subjects/Keywords: Pharmaceutical sciences; Antigens; Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Williams, J. Z. (2019). Engineering T cells with diverse mechanisms for improved tumor recognition precision. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/0zn3g33t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Williams, Jasper Zee. “Engineering T cells with diverse mechanisms for improved tumor recognition precision.” 2019. Thesis, University of California – San Francisco. Accessed March 05, 2021. http://www.escholarship.org/uc/item/0zn3g33t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Williams, Jasper Zee. “Engineering T cells with diverse mechanisms for improved tumor recognition precision.” 2019. Web. 05 Mar 2021.

Vancouver:

Williams JZ. Engineering T cells with diverse mechanisms for improved tumor recognition precision. [Internet] [Thesis]. University of California – San Francisco; 2019. [cited 2021 Mar 05]. Available from: http://www.escholarship.org/uc/item/0zn3g33t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Williams JZ. Engineering T cells with diverse mechanisms for improved tumor recognition precision. [Thesis]. University of California – San Francisco; 2019. Available from: http://www.escholarship.org/uc/item/0zn3g33t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

24. Berinstein, Elliot. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.

Degree: 2016, University of Toronto

The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a promising treatment for various cancers. CARs have been shown to redirect… (more)

Subjects/Keywords: Cancer; Gene Therapy; Immunotherapy; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Berinstein, E. (2016). The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/90143

Chicago Manual of Style (16th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Masters Thesis, University of Toronto. Accessed March 05, 2021. http://hdl.handle.net/1807/90143.

MLA Handbook (7th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Web. 05 Mar 2021.

Vancouver:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/1807/90143.

Council of Science Editors:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/90143

25. O'donnell, Kyle. Avian IgY As An Immunotherapy For Flaviviral Infections.

Degree: PhD, Biomedical Sciences, 2019, University of North Dakota

  Flaviviruses compose a group of positive single strand RNA viruses. This group possess 70 individual viruses that cause disease in humans and animals. This… (more)

Subjects/Keywords: Dengue; Flavivirus; IgY; Immunotherapy; Zika

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'donnell, K. (2019). Avian IgY As An Immunotherapy For Flaviviral Infections. (Doctoral Dissertation). University of North Dakota. Retrieved from https://commons.und.edu/theses/2478

Chicago Manual of Style (16th Edition):

O'donnell, Kyle. “Avian IgY As An Immunotherapy For Flaviviral Infections.” 2019. Doctoral Dissertation, University of North Dakota. Accessed March 05, 2021. https://commons.und.edu/theses/2478.

MLA Handbook (7th Edition):

O'donnell, Kyle. “Avian IgY As An Immunotherapy For Flaviviral Infections.” 2019. Web. 05 Mar 2021.

Vancouver:

O'donnell K. Avian IgY As An Immunotherapy For Flaviviral Infections. [Internet] [Doctoral dissertation]. University of North Dakota; 2019. [cited 2021 Mar 05]. Available from: https://commons.und.edu/theses/2478.

Council of Science Editors:

O'donnell K. Avian IgY As An Immunotherapy For Flaviviral Infections. [Doctoral Dissertation]. University of North Dakota; 2019. Available from: https://commons.und.edu/theses/2478


Victoria University of Wellington

26. Cameron, Alanna. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.

Degree: 2015, Victoria University of Wellington

 Metastatic melanoma is the most aggressive form of skin cancer, associated with a poor prognosis, and the incidence worldwide is increasing. Recently, selective mutant BRAF… (more)

Subjects/Keywords: Melanoma; Immunotherapy; BRAF inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cameron, A. (2015). Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. (Doctoral Dissertation). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/4937

Chicago Manual of Style (16th Edition):

Cameron, Alanna. “Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.” 2015. Doctoral Dissertation, Victoria University of Wellington. Accessed March 05, 2021. http://hdl.handle.net/10063/4937.

MLA Handbook (7th Edition):

Cameron, Alanna. “Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.” 2015. Web. 05 Mar 2021.

Vancouver:

Cameron A. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. [Internet] [Doctoral dissertation]. Victoria University of Wellington; 2015. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10063/4937.

Council of Science Editors:

Cameron A. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. [Doctoral Dissertation]. Victoria University of Wellington; 2015. Available from: http://hdl.handle.net/10063/4937


University College London (University of London)

27. Seah, Geok Teng. Type-2 cytokines in the immunopathology of tuberculosis.

Degree: PhD, 2000, University College London (University of London)

 Immune correlates of protective and deleterious host responses in human tuberculosis are not well understood, but this knowledge is central to the design of new… (more)

Subjects/Keywords: 572; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Seah, G. T. (2000). Type-2 cytokines in the immunopathology of tuberculosis. (Doctoral Dissertation). University College London (University of London). Retrieved from https://discovery.ucl.ac.uk/id/eprint/10101028/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325816

Chicago Manual of Style (16th Edition):

Seah, Geok Teng. “Type-2 cytokines in the immunopathology of tuberculosis.” 2000. Doctoral Dissertation, University College London (University of London). Accessed March 05, 2021. https://discovery.ucl.ac.uk/id/eprint/10101028/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325816.

MLA Handbook (7th Edition):

Seah, Geok Teng. “Type-2 cytokines in the immunopathology of tuberculosis.” 2000. Web. 05 Mar 2021.

Vancouver:

Seah GT. Type-2 cytokines in the immunopathology of tuberculosis. [Internet] [Doctoral dissertation]. University College London (University of London); 2000. [cited 2021 Mar 05]. Available from: https://discovery.ucl.ac.uk/id/eprint/10101028/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325816.

Council of Science Editors:

Seah GT. Type-2 cytokines in the immunopathology of tuberculosis. [Doctoral Dissertation]. University College London (University of London); 2000. Available from: https://discovery.ucl.ac.uk/id/eprint/10101028/ ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325816


University of Plymouth

28. Goddard, Ruth Victoria. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.

Degree: PhD, 2002, University of Plymouth

Immunotherapy using dendritic cells has shown encouraging results in both haematological and non-haematological malignancies. In this study, monocyte-derived dendritic cells from patients with B-cell Chronic… (more)

Subjects/Keywords: 616; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Goddard, R. V. (2002). Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. (Doctoral Dissertation). University of Plymouth. Retrieved from http://hdl.handle.net/10026.1/2695

Chicago Manual of Style (16th Edition):

Goddard, Ruth Victoria. “Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.” 2002. Doctoral Dissertation, University of Plymouth. Accessed March 05, 2021. http://hdl.handle.net/10026.1/2695.

MLA Handbook (7th Edition):

Goddard, Ruth Victoria. “Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.” 2002. Web. 05 Mar 2021.

Vancouver:

Goddard RV. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. [Internet] [Doctoral dissertation]. University of Plymouth; 2002. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10026.1/2695.

Council of Science Editors:

Goddard RV. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. [Doctoral Dissertation]. University of Plymouth; 2002. Available from: http://hdl.handle.net/10026.1/2695

29. Thomas, Myles Duncan. Production and characterisation of novel human monoclonal antibodies against malignant melanoma.

Degree: PhD, 1995, University of East London

 Malignant melanoma is an immunogenic tumour capable of inducing a humoral immune response, as shown by tumour-reactive serum antibody in patients. Lack of effective chemotherapy… (more)

Subjects/Keywords: 610.28; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thomas, M. D. (1995). Production and characterisation of novel human monoclonal antibodies against malignant melanoma. (Doctoral Dissertation). University of East London. Retrieved from https://repository.uel.ac.uk/item/86q8w ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262193

Chicago Manual of Style (16th Edition):

Thomas, Myles Duncan. “Production and characterisation of novel human monoclonal antibodies against malignant melanoma.” 1995. Doctoral Dissertation, University of East London. Accessed March 05, 2021. https://repository.uel.ac.uk/item/86q8w ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262193.

MLA Handbook (7th Edition):

Thomas, Myles Duncan. “Production and characterisation of novel human monoclonal antibodies against malignant melanoma.” 1995. Web. 05 Mar 2021.

Vancouver:

Thomas MD. Production and characterisation of novel human monoclonal antibodies against malignant melanoma. [Internet] [Doctoral dissertation]. University of East London; 1995. [cited 2021 Mar 05]. Available from: https://repository.uel.ac.uk/item/86q8w ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262193.

Council of Science Editors:

Thomas MD. Production and characterisation of novel human monoclonal antibodies against malignant melanoma. [Doctoral Dissertation]. University of East London; 1995. Available from: https://repository.uel.ac.uk/item/86q8w ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262193

30. Šilanskas, Mantas. Oncolytic viruses armed with immunostimulatory genes for cancer treatment.

Degree: Biology Education Centre, 2018, Uppsala UniversityUppsala University

  Cancer is a major health burden in modern society, costing millions of lives worldwide and negatively impacting many more. With increasing rates of cancer,… (more)

Subjects/Keywords: Cancer; Virus; Immunotherapy; Immunology; Immunologi

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Šilanskas, M. (2018). Oncolytic viruses armed with immunostimulatory genes for cancer treatment. (Thesis). Uppsala UniversityUppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Šilanskas, Mantas. “Oncolytic viruses armed with immunostimulatory genes for cancer treatment.” 2018. Thesis, Uppsala UniversityUppsala University. Accessed March 05, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Šilanskas, Mantas. “Oncolytic viruses armed with immunostimulatory genes for cancer treatment.” 2018. Web. 05 Mar 2021.

Vancouver:

Šilanskas M. Oncolytic viruses armed with immunostimulatory genes for cancer treatment. [Internet] [Thesis]. Uppsala UniversityUppsala University; 2018. [cited 2021 Mar 05]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Šilanskas M. Oncolytic viruses armed with immunostimulatory genes for cancer treatment. [Thesis]. Uppsala UniversityUppsala University; 2018. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [39]

.